Sprint Bioscience AB (SPRINT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
22 Pages - GLDATA58324
$250.00

Summary

Sprint Bioscience AB (Sprint Bioscience) is a pharmaceutical company that discovers and develops cancer and metabolism drugs. The company’s products comprise cancer metabolism, autophagy and amino acid metabolism. It operates projects which include PIP4K2a, and Vps34, established FBDD project, develop in vivo candidate and develop clinical candidate. Sprint Bioscience builds drug discovery pipeline of innovative targets within oncology. The company also provides out-licensing which include from the discovery phase to clinical trials. Its expertise’s in metabolism that applies outside the cancer area and also evaluates projects in the areas of diabetes. The company collaborates with universities and individual researchers across Sweden. Sprint Bioscience is headquartered in Huddinge, Sweden.

Sprint Bioscience AB (SPRINT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sprint Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Sprint Bioscience Raises Funds Through Venture Financing 10
Partnerships 11
Sprint Bioscience Enters into Research Agreement with Karolinska Institutet 11
Sprint Bioscience Enters into Co-Development Agreement with University of Gothenburg 12
TPP Global Development Enters Into Agreement With Sprint Biosciences To Develop Choline Kinase Inhibitors 13
Licensing Agreements 14
Petra Pharma Enters into Licensing Agreement with Sprint Bioscience 14
Sprint Bioscience Enters into Licensing Agreement with Bayer HealthCare 15
Equity Offering 16
Sprint Bioscience to Raise USD2.3 Million in Private Placement of Shares 16
Sprint Bioscience Raises USD3 Million in IPO 17
Asset Transactions 18
Kancera Acquires PFKFB3 from Sprint Bioscience 18
Sprint Bioscience AB - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sprint Bioscience AB, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sprint Bioscience AB, Deals By Therapy Area, 2010 to YTD 2016 8
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Sprint Bioscience Raises Funds Through Venture Financing 10
Sprint Bioscience Enters into Research Agreement with Karolinska Institutet 11
Sprint Bioscience Enters into Co-Development Agreement with University of Gothenburg 12
TPP Global Development Enters Into Agreement With Sprint Biosciences To Develop Choline Kinase Inhibitors 13
Petra Pharma Enters into Licensing Agreement with Sprint Bioscience 14
Sprint Bioscience Enters into Licensing Agreement with Bayer HealthCare 15
Sprint Bioscience to Raise USD2.3 Million in Private Placement of Shares 16
Sprint Bioscience Raises USD3 Million in IPO 17
Kancera Acquires PFKFB3 from Sprint Bioscience 18
Sprint Bioscience AB, Key Competitors 19
Sprint Bioscience AB, Key Employees 20

List of Figures
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sprint Bioscience AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838